Clovis Oncology, Inc. Quarterly Costs and Expenses in USD from Q1 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Clovis Oncology, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2020 to Q3 2022.
  • Clovis Oncology, Inc. Costs and Expenses for the quarter ending September 30, 2022 was $74.9M, a 21.5% decline year-over-year.
  • Clovis Oncology, Inc. Costs and Expenses for the twelve months ending September 30, 2022 was $340M, a 13.8% decline year-over-year.
  • Clovis Oncology, Inc. annual Costs and Expenses for 2021 was $375M, a 19.8% decline from 2020.
  • Clovis Oncology, Inc. annual Costs and Expenses for 2020 was $467M, a 10.2% decline from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $340M $74.9M -$20.5M -21.5% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $360M $91.5M -$2.88M -3.05% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $363M $84.6M -$11.5M -11.9% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $375M $88.7M -$19.6M -18.1% Oct 1, 2021 Dec 31, 2021 10-K 2022-02-24
Q3 2021 $394M $95.4M -$15.9M -14.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $410M $94.4M -$28.1M -23% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $438M $96.1M -$28.5M -22.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $467M $108M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $111M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $123M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $125M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.